Antiviral activity of Engystol® and Gripp-Heel®: An in-vitro assessment

Journal of Immune Based Therapies and Vaccines

Volumn 8, Issue , 2010, Pages

  Roeska, Kerstin ^a   Seilheimer, Bernd ^a  

^a Biologische Heilmittel Heel GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ECHINACEA EXTRACT; ENGYSTOL; INTERFERON; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; DRUG EFFICACY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON PRODUCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; VIRAL RESPIRATORY TRACT INFECTION;

EID: 78149493522     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-8-6     Document Type: Article

References (28)

1. Herzberger G, Weiser M. Homeopathic Treatment of Infections of Various Origins: A Prospective Study. Biomedical Therapy 1997, 14:123-127.
2. Heilmann A. Ein injizierbares Kombinationspräparat (Engystol N) als Prophylaktikum des grippalen Infekts. Biol Med 1992, 21:225-229.
3. Schmiedel V, Klein P. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: An observational study. Explore (NY) 2006, 2:109-114.
4. Rabe A. Symptomatic treatment of acute upper respiratory infections: a comparison of homeopathic and conventinoal therapies. Der Allgemeinarzt 2003, 25:1522-1530.
5. Rabe A, Weiser M, Klein P. Effectiveness and tolerability of a homoeopathic remedy compared with conventional therapy for mild viral infections. Int J Clin Pract 2004, 58:827-832. 10.1111/j.1742-1241.2004.00150.x, 15529515.
6. Glatthaar-Saalmuller B. In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel on selected respiratory viruses. Can J Physiol Pharmacol 2007, 85:1084-1090. 10.1139/Y07-100, 18066110.
7. Oberbaum M, Glatthaar-Saalmuller B, Stolt P, Weiser M. Antiviral activity of Engystol: an in vitro analysis. J Altern Complement Med 2005, 11:855-862. 10.1089/acm.2005.11.855, 16296918.
8. Enbergs H. Effects of the homeopathic preparation Engystol on interferon-gamma production by human T-lymphocytes. Immunol Invest 2006, 35:19-27. 10.1080/08820130500496753, 16531327.
9. Fimiani VC, Antonia, Ainis, Tommaso. Immunomodulatory Effect of the Homoeopathic Drug Engystol-N on Some Activities of Isolated Human Leucocytes and in Whole Blood. Immunopharmacology and Immunotoxicology 2000, 22:103-115. 10.3109/08923970009016409, 10737260.
10. Matusiewicz R. The effect of a homeopathic preparation on the clinical condition of patients with corticosteroid-dependent bronchial asthma. Biomed Ther 1997, 15:70-74.
11. Siewierrska K, Denys A. Efficacy of preoperative immunoprophylaxis in patients with neoplastic deseases. I. Phagocyte activity and bactericidal properties of peripheral blood granulocytes. Int Rev Allergol Clin Immunol 1999, 5:39-45.
12. Siewierrska K, Denys A. Efficacy of preoperative immunoprophylaxis in patients with neoplastic deseases. II. Estimation of antihaemagglutinin and antineuraminidase antibody titre or influenza viruses A and B. Int Rev Allergol Clin Immunol 1999, 5:46-50.
13. Wagner H, Jurcic K. Immunological studies of plant-extract combinations - invitro and invivo studies on the stimulation of phagocytosis. Arzneimittel-Forschung/Drug Research 1991, 41(2):1072-1076.
14. Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002, 2:675-687. 10.1038/nri888, 12209136.
15. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007, 282:15325-15329. 10.1074/jbc.R700002200, 17395583.
16. Knipe DM, Samuel CE, Pales P. Virus-host cell interactions. Fields virology 4th edition 2001, 133-170. Philadelphia: Lippincott Raven, Knipe DM, Howley PM, Griffin DE, Martin M, Roizman B, Straus SE, 4.
17. Honda K, Yanai H, Takaoka A, Taniguchi T. Regulation of the type I IFN induction: a current view. Int Immunol 2005, 17:1367-1378. 10.1093/intimm/dxh318, 16214811.
18. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 2004, 24:439-454. 10.1089/1079990041689665, 15320958.
19. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001, 14:778-809, table of contents. 10.1128/CMR.14.4.778-809.2001, 89003, 11585785.
20. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28. 10.1016/j.immuni.2005.04.010, 16039576.
21. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643. 10.1126/science.1087262, 12855817.
22. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003, 198:513-520. 10.1084/jem.20030162, 2194085, 12900525.
23. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101:1315-1320. 10.1073/pnas.0308057100, 337050, 14739339.
24. Ankel H, Westra DF, Welling-Wester S, Lebon P. Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 1998, 251:317-326. 10.1006/viro.1998.9432, 9837796.
25. Lebon P. Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs. J Gen Virol 1985, 66(Pt 12):2781-2786. 10.1099/0022-1317-66-12-2781, 2999320.
26. Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 1998, 273:29210-29217. 10.1074/jbc.273.44.29210, 9786932.
27. Dai J, Megjugorac NJ, Amrute SB, Fitzgerald-Bocarsly P. Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J Immunol 2004, 173:1535-1548.
28. Biron CA. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin Immunol 1998, 10:383-390. 10.1006/smim.1998.0138, 9799713.